Melting points were measured on a Yanagimoto melting point apparatus (Kyoto, Japan) and were uncorrected. IR spectra were recorded on a PerkinElmer FT-IR 1725X spectrophotometer, and ultraviolet (UV) spectra were determined in 95% EtOH on a Hitachi 150-20 UV spectrometer (Tokyo, Japan). 1 H-NMR spectra were obtained in CDCl 3 solution with a JEOL GX 400 (400 MHz) or JEOL LA 600 (600 MHz) spectrometer (Tokyo, Japan) using tetramethylsilane as an internal standard, and MS spectra (EI mode) with a JEOL JMS-DX 303 spectrometer. TLC was performed on E. Merck precoated silica gel plates (silica gel 60F-254, Darmstadt, Germany). Column chromatography was conducted with silica gel 60, 70-230 mesh (E. Merck).
Aromatase is a cytochrome P-450 enzyme responsible for catalyzing the conversion of the androgens, androstenedione (AD) and testosterone to the estrogens, estrone and estradiol, respectively. [1] [2] [3] This process appears to proceed with three oxygenations of the androgens, each of which requires 1 mol of O 2 and 1 mol of reduced nicotinamide adenine dinucleotide phosphate (NADPH). The 19-methyl group, as well as 1b and 2b-hydrogens, are eliminated in the third oxygenative step, resulting in aromatization of the A-ring of the androgens. [4] [5] [6] [7] [8] [9] [10] The exact nature of the final step remains uncertain, however; the A-ring conformation is thought to play a critical role in the stereospecific removal of the two hydrogens.
Aromatase inhibitors are useful in treating estrogendependent breast cancer. 11) Therefore, several categories of steroidal and non-steroidal inhibitors were designed. Osawa and co-workers reported previously that the natural estrogen, which was thought to be the final product of aromatase reaction, served as an inhibitor of aromatase, yielding catechol estrogen, 2-hydroxyestrone, as well as 6a-hydroxyestrone. [12] [13] [14] We previously reported structure-activity relationships of estrogen analogs as aromatase inhibitors to know the spatial aspects of the active site of aromatase and to develop a novel series of aromatase inhibitors. 15) Consequently, 2-halogeno-, 2-methyl-, 6a-aryl-, and 6b-methylestrones are good competitive inhibitors of aromatase in human placental microsomes (apparent K i 's ranging between 100 and 660 nM). On the other hand, many compounds have been reported as non-steroidal competitive inhibitors of aromatase, including flavonoids and their analogs. [16] [17] [18] [19] They have a heteroatom (sulfur, oxygen, and nitrogen) that would bind to the heme iron of the aromatase cytochrome P-450 enzyme. In particular, flavonoids having a nitrogen-containing heterocylic moiety such as pyridine, pyrimidine, imidazole, and triazole strongly inhibit aromatase. 19) In this study, we examined the structure-activity relationships of the pyridine and other heterocyclic derivatives of estrone and estradiol analogs as aromatase inhibitors in human placental microsomes. Isonicotinyl-substituted derivatives 5c and 10c were the most potent inhibitors of aromatase. H-NMR spectra were obtained in CDCl 3 solution with a JEOL GX 400 (400 MHz) or JEOL LA 600 (600 MHz) spectrometer (Tokyo, Japan) using tetramethylsilane as an internal standard, and MS spectra (EI mode) with a JEOL JMS-DX 303 spectrometer. TLC was performed on E. Merck precoated silica gel plates (silica gel 60F-254, Darmstadt, Germany). Column chromatography was conducted with silica gel 60, 70-230 mesh (E. Merck).
2-and 4-Nitro-3-benzyloxyestra-1,3,5-triene-17-ones (2, 7) A solution of 2-or 4-nitroestrone (1, 6) (2.35 g, 7.46 mmol) in CH 3 CN (85 ml) was added benzyl bromide (1.075 ml, 7.46 mmol) and anhydrous K 2 CO 3 (6.85 g, 49.7 mmol). The mixture was refluxed with stirring for 1 h. The reaction mixture was filtered and evaporated which was recrystallized from acetone to give 2-and 4-nitro-3-benzyloxy steroid 2 or 7 (2.96 g or 2.90 g, 98.0% or 96.0%), respectively. 2-and 4-Substituted 3-Benzyloxyestra-1,3,5-triene-17-ones (4, 9) A solution of 2-amino steroid 3 (260 mg, 0.70 mmol) in anhydrous DMF (43 ml) was added picolinoyl chloride hydrochloride (249 mg, 1.4 mmol) and pyridine (55 ml) and refluxed for 2 h. The reaction mixture was evaporated under the reduced pressure, and the resulting residue was purified by column chromatography (hexane-EtOAc, 5 : 1, v/v) followed by recrystallization from acetone to afford 2-picolinylamide steroid 4a (122 mg, 36%). 2-Nicotinyl, isonicotinyl, and isoxazolecarbonyl substituted compounds 4b, 4c, and 4d and 4-picolinyl, nicotinyl, isonicotinyl, and isoxazolecarbonyl substituted compounds 9 were also obtained from steroid 3 or 8 in the similar manner as described above.
2-and 4-Substituted Estra-1,3,5-triene-17-ones (5 or 10) A mixture of 3-benzyloxy steroid 4a (122 mg, 0.26 mmol), Pd-C (390 mg), and 95% EtOH (63 ml) was stirred under hydrogen atmosphere for 2.5 h. The reaction mixture was filterd and evaporated, the residue which was recrystallized from acetone gave 3-hydroxy-2-picolinyl compound 5a (42.0 mg, 42%). Other 3-benzyloxy steroids 4b-d and steroids 9 were hydrogenated, similarly as above, to yield 3-hydroxy-2-substituted steroids 5b-d and their 4-isomers 10.
3-Substituted Estrones (12) Method 1: A mixture of 2-methyl-6-nitrobenzoic anhydride (MNBA) (191 mg), 4-dimethylaminopyridine (DMAP) (46 mg), 2-furancarboxylic acid (62 mg) in THF (1 ml) and triethylamine (0.1 ml) were added to a solution of estrone (11) (30 mg, 0.11 mmol) in THF (1 ml). [21] [22] [23] The resulting mixture was stirred at room temperature for 1 h. Then the reaction mixture was diluted with EtOAc, washed with 5% NaHCO 3 and water, and dried with Na 2 SO 4 . After evaporation of the solvent, the crude obtained was recrystallized from acetone to yield 12a. 3-Thiophenecarbonyl, thiazolecarbonyl, and pyrrolecarbonyl substituted estrones (12b-d) were synthesized similarly as described for the synthesis of 12a.
Method 2: 5-Isoxazolecarbonyl chloride (120 mg, 0.91 mmol) in pyridine (6 ml) were added to a solution of estrone (11) (31 mg, 0.11 mmol) in CH 3 CN (6 ml) and the mixture was stirred at 60°C for 9 h. The reaction mixture was poured into water and extracted with EtOAc. The organic layer was washed with sat. NaHCO 3 and water, dried with Na 2 SO 4 , and purified by recrystallization from EtOAc to give steroid 12e (29 mg, 70%).
3-tert-Butyldimethylsiloxy-17b b-substituted Estradiols (14) Method 1: A mixture of MNBA (688 mg), DMAP (171 mg), 2-furancarboxylic acid (220 mg, 2.0 mmol) in THF (5 ml) and triethylamine (0.5 ml) were added to a solution of steroid 13 (153 mg, 0.40 mmol) in THF (5 ml), and the mixture was stirred at room temperature for 1 h. The reaction mixture was poured to sat. NaHCO 3 and extracted with EtOAc. The organic layer was washed with water, and dried with Na 2 SO 4 . Evaporation of the solvent followed by recrystallization from acetone gave steroid 14a. 17-Thiophenecarbonyl and thiazolecarbonyl substituted compounds 14b and 14c were prepared in the similar manner as the synthesis of 14a.
Method 2: 5-Isoxazolecarbonyl chloride (184 mg, 1.40 mmol) was reacted with 13 (126 mg, 0.33 mmol) under above condition, a crude product purified by column chromatography (hexane-EtOAc, 9 : 1, v/v) to give 14d (54 mg, 35%).
17b b-Substituted Estradiols (15) 1 mol/l HCl solution (3.8 ml) was added to a mixture of steroid 14a (123 mg, 0.26 mmol), isopropanol (2.5 ml), and THF (6.5 ml). The reaction mixture was allowed to stand at room temperature for over night, and the mixture was diluted with EtOAc. The organic layer was washed with sat. NaHCO 3 and water, and dried with Na 2 SO 4 . Evaporation of the solvent, followed by recrystallization from acetone gave steroid 15a (82 mg, 87%). Other 17-substituted estradiols (15b-d) were obtained by the deprotection of the 3-silylether 10b-d similarly as described for the preparation of 15a.
Enzyme Preparation Human placental microsomes (sedimented after 60 min at 105000ϫg) were obtained as described by Ryan. 24) They were washed once with 0.05 mM dithiothreitol, lyophilized and stored at Ϫ80°C. No significant loss of activity occurred during the period (6 months) of this study. The preparation of human placental microsomes was conducted under the approval of the ethical review committee of Tohoku Pharmaceutical University in accordance with the standard of the Helsinki Declaration.
Aromatase Assay Procedure Aromatase activity was measured essentially according to the original procedure of Siiteri and Thompson. 25) All enzymatic studies were carried out in 67 mM phosphate buffer, pH 7.5, at a final volume of 500 ml under initial velocity conditions. The incubation mixture for the IC 50 experiment contained 480 mM of NADPH, 300 nM of [1b- Apparent K i values were calculated using non-linear regression analysis with GraFit software.
27)

Results and Discussion
Chemistry Previously, it has been reported that estrone is more potent inhibitor of human placental aromatase, compared to estradiol, although the estrogens are the aromatase final products. Then, we first employed estrone as a scaffold of aromatase inhibitors for the synthesis of the estrogen derivatives. 2-or 4-nitroestrone (1 or 6) was treated with benzyl bromide in CH 3 CN in the presence of K 2 CO 3 gave 3-benzyl ethers 2 or 7 which was reduced with Na 2 S 2 O 4 to yield 2-or 4-aminoestone 3-benzyl ether (3 or 8) (Fig. 1) . Treatment of 2-aminoestone 3-benzyl ether (3) with acid chloride (picolinoyl chloride, nicotinoyl chloride, isonicotinoyl chloride, or 5-isoxazolecarbonyl chloride) in pyridine gave 2-amide derivatives 4 having a heterocyclic ring at C-2 in fair yield (Tables 1, 2). Deprotection of a 3-benzyl function of compounds 4 with H 2 /C afforded finally 2-heterocyclic-substituted amides 5. 4-Heterocyclic-substituted aminoestrones (10) were synthesized similarly as described for the synthesis of the 2-isomers 5.
Next, we employed estrone for a starting material of synthesis of estrone 3-heterocyclic-substituted derivatives 12 (Fig. 2) . Estrone (11) was treated with 2-furancarboxylic acid, 2-thiophenecarboxylic acid, 4-thiazolecarboxylic acid, or pyrrole-2-carboxylic acid under the mixed anhydride condition (MNBA in the presence of DMAP and triethylamine) in THF for 1 h to afford to estrone 3-heterocyclic esters 12a-d whereas the 3-isoxazolecarbonyl ester 12d was obtained with 5-isoxazolecarbonyl chloride in pyridine (Table  3) . Finally, we prepared estradiol 17-heterocyclic-substituted derivatives 15 (Fig. 3) . 3-tert-Butyldimethylsiloxyestradiol (13) was converted into 17-heterocyclic esters 14 by treatment with the mixed anhydride method or the acyl chloride in pyridine as described for the synthesis of compound 12. Hydrolysis of the 3-silyl ethers 14 with 1 mol/l HCl in propan-2-ol and THF gave 17-heterocyclic-substituted estradiol (15) in good yields (Tables 4, 5) .
Spectral data for all of the compounds synthesized in this study were consistent with the assigned structures.
Biological Properties Inhibition of aromatase activity using [1b- 3 H]AD as a substrate in human placental microsomes by the estrogen derivatives was examined in vitro by enzyme kinetics. This assay quantitates the production of tritiated water released from [1b-3 H]AD by aromatization. The effects of varying the C-2, C-4, and C-3 substitution of estrone and the C-17 substitution of estradiol on the activity of androstenedione aromatization was determined in relation to the aromatase-catatyzed estrogen hydroxylations, especially the catechol estrogen formation. The results are shown in Table 6 . IC 50 values were initially obtained under initial velocity conditions. 2-Amides 5a-c, picolinyl (5a), nicotinyl (5b) and isonicotinyl (5c) amides, as well as 4-amide derivatives 6a-c showed fairly inhibitory activity but 4-isoxazole derivatives 5d and 10d were poor inhibitors. Moreover, estrone 3-and estradiol 17-furancarbonyl, thiophenecarbonyl, thiazolecarbonyl, and isoxazolecarbonyl esters (12, 15) did not show any detectable amounts of the aromatase inhibitory activity. Among the inhibitors examined, the apparent inhibition constants (K i ), an index of the ability of the enzyme for the inhibitor, were obtained for isonicotinyl compounds 5c and 10c by analysis of a Dixon plot. The two compounds were evaluated as competitive or non-competitive inhibitors of aromatase in human placental microsomes. LineweaverBurk plots showed that these were competitive inhibitors (Fig. 4) . Isonicotinyl analogs 5c and 10c were most potent inhibitors and their apparent K i values were 2.19Ϯ0.14 mM and 1.53Ϯ0.08 mM for 5c and 10c, respectively. Nicotinyl derivatives 5b and 10b and picolinyl derivatives 5a and 10a were less potent inhibitors. For comparison, the K i values of estrone and estradiol were determined to be 2.50Ϯ0.22 mM and 130Ϯ10 mM, respectively. Introduction of fluoro, chloro, bromo, methyl, and formyl groups at C-2 of estrone gave rise to the markedly increased affinity for aromatase but that of methoxy, nitro, amino functions at the C-2 position did not affect, to a significant extent, the affinity. 15) On the other hand, the similar substitution at the 4-position of estrone markedly decreased the affinity. The present results shows that there is no significant difference between the 2-and 4-subsituted compounds, demonstrating that there are the similar accessible volume between C-2 and C-4 positions. Although there is no precise evidence concerning the relation of aromatase-catalyzed 2-hydroxylation of estrogen to the aromatase reaction, estrogen formation, the accessible volume of the C-2 and C-4 position would play as critical role to the both the hydroxylation and the aromatase reaction. Among the pyridine substitutions, the fact that the isonicotinyl derivatives 5c and 10c were most potent ones suggests that the N-hetero atom, orienting p-position on the pyridine ring, is most fitted the accessible volume. The coordination of the para N atom of pyridine to the heme-Fe of aromatase would be involved in the inhibition. Compounds having the other heterocyclic ring at the C-3 of estrone and at C-17 of estradiol did not access the binding pocket, namely, the hetero atoms of the heterocyclic compounds failed the coordination to the heme moiety of aromatase.
The 2-and 4-isonicotinyl amino derivatives of estrone, compounds 5c and 10c, were promising compounds for further powerful aromatase inhibitors. On the basis of the results, it is presumed that there would be an accessible volume in the regions of C-2 and C-4 positions. 
